Dr. Carla Casulo, MD
Claim this profileUniversity of Rochester
Studies Cancer
Studies Diffuse Large B-Cell Lymphoma
4 reported clinical trials
11 drugs studied
Area of expertise
1Cancer
IGH:BCL2 fusion negative
STAT6 positive
1p36 deletion positive
2Diffuse Large B-Cell Lymphoma
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Carla Casulo, MD is currently running
Rituximab vs Mosunetuzumab
for Follicular Lymphoma
This phase III trial compares the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden. Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This may help the immune system kill cancer cells. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. It is not yet known if giving rituximab or mosunetuzumab works better in treating patients with follicular lymphoma with a low tumor burden.
Recruiting2 awards Phase 313 criteria
PET Adapted Therapy
for Non-Hodgkin's Lymphoma
The overarching goals of this study are to measure levels of circulating tumor DNA (ctDNA) in patients with early stage diffuse large B cell lymphoma (DLBCL), to assess the change in ctDNA during treatment in order to prospectively identify markers of treatment failure, and to use ctDNA as a future tool for response adapted therapy.
Recruiting1 award Phase 210 criteria
More about Carla Casulo, MD
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Carla Casulo, MD has experience with
- Rituximab
- Cyclophosphamide
- Doxorubicin
- Prednisone
- Vincristine
- Duvelisib
Breakdown of trials Carla Casulo, MD has run
Cancer
Diffuse Large B-Cell Lymphoma
Non-Hodgkin's Lymphoma
T-Cell Lymphoma
Peripheral T-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Carla Casulo, MD specialize in?
Carla Casulo, MD focuses on Cancer and Diffuse Large B-Cell Lymphoma. In particular, much of their work with Cancer has involved IGH:BCL2 fusion negative patients, or patients who are STAT6 positive.
Is Carla Casulo, MD currently recruiting for clinical trials?
Yes, Carla Casulo, MD is currently recruiting for 3 clinical trials in Rochester New York. If you're interested in participating, you should apply.
Are there any treatments that Carla Casulo, MD has studied deeply?
Yes, Carla Casulo, MD has studied treatments such as Rituximab, Cyclophosphamide, Doxorubicin.
What is the best way to schedule an appointment with Carla Casulo, MD?
Apply for one of the trials that Carla Casulo, MD is conducting.
What is the office address of Carla Casulo, MD?
The office of Carla Casulo, MD is located at: University of Rochester, Rochester, New York 14627 United States. This is the address for their practice at the University of Rochester.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.